Abbott Labs (ABT) Defended at Wells Fargo After Competitor Investment Conference Presentation Pressures Shares
Tweet Send to a Friend
Wells Fargo analyst Larry Biegelsen reiterated an Overweight rating on Abbott Labs (NYSE: ABT) after Quidel Corp (NASDAQ: QDEL) reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
